Literature DB >> 22652347

New methods can extend the use of minimal important difference units in meta-analyses of continuous outcome measures.

Bradley C Johnston1, Kristian Thorlund, Bruno R da Costa, Toshi A Furukawa, Gordon H Guyatt.   

Abstract

OBJECTIVE: For continuous outcomes measured using instruments with an established minimally important difference (MID), pooled estimates can be usefully reported in MID units. Approaches suggested thus far omit studies that used instruments without an established MID. We describe an approach that addresses this limitation. STUDY
DESIGN: Using the ratio of MID to standard deviation in the trials with an established MID, we imputed the MID for instruments without an established MID and pooled across all trials. We applied this approach to two meta-analyses.
RESULTS: In 20 trials of respiratory rehabilitation, the pooled estimate did not differ significantly between trials with an established MID and those without an established MID (interaction P=0.23). The same was true for 52 trials examining amitriptyline vs. other antidepressants (interaction P=0.54). In the respiratory example, the addition of trials without an established MID led to little change in point estimates or confidence intervals (CIs, more data balanced by more heterogeneity in a random effects model). In the antidepressant example, the additional trials resulted in an identical point estimate with a narrowing of the CI.
CONCLUSION: Our method allows estimates of a pooled effect in MID units using both trials with and without an established MID.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652347     DOI: 10.1016/j.jclinepi.2012.02.008

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  8 in total

1.  Do clinicians understand the size of treatment effects? A randomized survey across 8 countries.

Authors:  Bradley C Johnston; Pablo Alonso-Coello; Jan O Friedrich; Reem A Mustafa; Kari A O Tikkinen; Ignacio Neumann; Per O Vandvik; Elie A Akl; Bruno R da Costa; Neill K Adhikari; Gemma Mas Dalmau; Elise Kosunen; Jukka Mustonen; Mark W Crawford; Lehana Thabane; Gordon H Guyatt
Journal:  CMAJ       Date:  2015-10-26       Impact factor: 8.262

2.  Patient-reported outcomes in meta-analyses-part 2: methods for improving interpretability for decision-makers.

Authors:  Bradley C Johnston; Donald L Patrick; Kristian Thorlund; Jason W Busse; Bruno R da Costa; Holger J Schünemann; Gordon H Guyatt
Journal:  Health Qual Life Outcomes       Date:  2013-12-21       Impact factor: 3.186

Review 3.  Minimally important difference estimates and methods: a protocol.

Authors:  Bradley C Johnston; Shanil Ebrahim; Alonso Carrasco-Labra; Toshi A Furukawa; Donald L Patrick; Mark W Crawford; Brenda R Hemmelgarn; Holger J Schunemann; Gordon H Guyatt; Gihad Nesrallah
Journal:  BMJ Open       Date:  2015-10-01       Impact factor: 2.692

4.  Opioids for chronic non-cancer pain: a protocol for a systematic review of randomized controlled trials.

Authors:  Jason W Busse; Stefan Schandelmaier; Mostafa Kamaleldin; Sandy Hsu; John J Riva; Per Olav Vandvik; Ludwig Tsoi; Tommy Lam; Shanil Ebrahim; Bradley Johnston; Lori Oliveri; Luis Montoya; Regina Kunz; Anna Malandrino; Neera Bhatnagar; Sohail M Mulla; Luciane C Lopes; Charlene Soobiah; Anthony Wong; Norman Buckley; Daniel Sessler; Gordon H Guyatt
Journal:  Syst Rev       Date:  2013-08-21

Review 5.  Patient-reported outcomes in meta-analyses--Part 1: assessing risk of bias and combining outcomes.

Authors:  Bradley C Johnston; Donald L Patrick; Jason W Busse; Holger J Schünemann; Arnav Agarwal; Gordon H Guyatt
Journal:  Health Qual Life Outcomes       Date:  2013-07-01       Impact factor: 3.186

6.  Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: the need to present minimal important differences units in meta-analyses.

Authors:  Silvia Gianola; Anita Andreano; Greta Castellini; Lorenzo Moja; Maria Grazia Valsecchi
Journal:  Health Qual Life Outcomes       Date:  2018-05-15       Impact factor: 3.186

7.  Presentation approaches for enhancing interpretability of patient-reported outcomes (PROs) in meta-analysis: a protocol for a systematic survey of Cochrane reviews.

Authors:  Tahira Devji; Bradley C Johnston; Donald L Patrick; Mohit Bhandari; Lehana Thabane; Gordon H Guyatt
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

8.  PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Giuseppe Filardo; Davide Previtali; Francesca Napoli; Christian Candrian; Stefano Zaffagnini; Alberto Grassi
Journal:  Cartilage       Date:  2020-06-19       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.